Cormorant Asset Management, LP's Form 4/A amendment
AmendedErasca, Inc. (ERAS) · filed Dec 21, 2022
- Accession no.
- 0000929638-22-001904
- Filed
- Dec 21, 2022, 4:33 PM ET
- Trade date
- Dec 13, 2022
- Filing delay
- 8 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Dec 20, 2022
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.00M. It was filed 8 days after the trade.
This amendment replaces 0000929638-22-001901 (filed Dec 20, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Director |
| Chen BihuaCIK 0001599214 | Director |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | Director |
| Cormorant Private Healthcare Fund II, LPCIK 0001747677 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | Common Stock | PPurchaseAcquired | +307,692 | $6.50 | +$1,999,998 | 10,813,246 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.